,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destinybreast04']
the results of the #destinybreast04 trial are so impressive! as an #immunologist i love following meetings such as #asco22 that overlap with my own practice as i always learn something new! this will be a game changer for many patients! 
FRCPC Internal Medicine - Clinical Immunology & Allergy. Lifelong learner, inspired by those around me! Views are my own.??